Reimbursed Care Access in Maldives

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The Maldives’ drug statutes and recent amendments create scheduling and penalty regimes that treat non‑medical possession, supply and import as criminal offences; the law also includes mechanisms to rapidly schedule emerging substances. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Maldives law aligns its schedules with the UN drug conventions and has recently expanded powers to list and penalize scheduled substances. # #.

Esketamine (the pharmaceutical product Spravato®) is not documented as an authorized, reimbursed medicine in Maldives public sources; ketamine itself is separately listed in Maldives controlled‑substance schedules (see below) and is recognized for medical/anesthetic use under regulatory control. Internationally, esketamine/Spravato has received regulatory approvals in multiple jurisdictions and is supplied under restricted clinic‑based programs (REMS‑style oversight) where approved. Therefore, in the Maldives context there is no evidence of a national reimbursement pathway or routine outpatient access to branded esketamine—any use would require formal registration/authorization and clinic‑level controls consistent with the product’s internationally established restricted‑use programs. # #.

Ketamine is explicitly listed in Maldives controlled‑substance schedules, and is treated by law as a controlled substance with recognized medical utility (e.g., anesthetic/medical use) subject to prescription, pharmacy and hospital controls. The national statutory schedules identify ketamine among listed substances, which in practice means it is available within the regulated health system for legitimate medical indications (principally anesthesia and other established hospital uses) but is tightly controlled for possession, import and distribution without authorization. # Recent legislative amendments reinforced scheduling powers and increased penalties for unauthorized trafficking and possession, underscoring strict regulatory oversight of controlled medicines. #

Clinical/coverage nuance: there is no public evidence of a national, standardized reimbursement program for IV/infusion ketamine for psychiatric indications (e.g., treatment‑resistant depression) analogous to reimbursement pathways in high‑income health systems. Ketamine’s legitimate medical use in Maldives is therefore effectively limited to conventional hospital/operative indications under health‑facility procurement and pharmacy regulation; off‑label psychiatric infusion or clinic‑based ketamine therapy would, if attempted, require institutional approval and would likely be paid privately unless a specific Ministry of Health reimbursement policy exists (no public registry or policy document establishing such reimbursement was identified in available government sources). # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Maldives scheduling and statutory language encompass psychotropic tryptamines and provide criminal penalties for unauthorized import, possession and supply. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The Maldives law provides mechanisms for listing emerging psychoactive substances and applies criminal sanctions to unauthorized use or distribution. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public record of regulated ibogaine treatment programs or authorized clinical access in the Maldives; unauthorized provision or import would be criminal under the scheduling/trafficking provisions. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Plant materials or brews containing scheduled tryptamines (e.g., DMT) are treated as controlled; no legal ceremonial or medical exemption appears to exist in Maldives law. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline and related phenethylamines are covered by the Maldivian scheduling framework and subject to criminal penalties for unauthorized possession, supply or import. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The Maldives legislative framework and amendment provisions specifically empower rapid scheduling of emerging psychoactive and designer substances, and criminal sanctions apply to unauthorised trafficking and possession. # #.